Thomas A Medsger MD
Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
3601 5th AveFalk Medical BuildingPittsburgh, PA 15213
Phone+1 412-647-6700
Dr. Medsger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Rheumatology, 1968 - 1969
UPMC Medical EducationResidency, Internal Medicine, 1965 - 1968
University of Miami/Jackson Health SystemInternship, Transitional Year, 1962 - 1963
Perelman School of Medicine at the University of PennsylvaniaClass of 1962
Certifications & Licensure
PA State Medical License 1966 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Top MD Consumers Checkbook
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Publications & Presentations
PubMed
- Gerald P Rodnan.Virginia D Steen, Thomas A Medsger
Rheumatic Diseases Clinics of North America. 2024-02-01 - 5 citationsA data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials.Robyn T Domsic, Thomas A Medsger, Shiyao Gao, Maureen Laffoon, Suiyuan Huang
Rheumatology. 2023-04-03 - 18 citationsAntifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.Maya Malaab, Ludivine Renaud, Naoko Takamura, Kip D. Zimmerman, Willian A. da Silveira
Annals of the Rheumatic Diseases. 2021-11-08
Journal Articles
- Anti‐RNPC3 (U11/U12) Antibodies in Systemic Sclerosis Are Associated with Moderate to Severe Gastrointestinal DysmotilityRobyn T Domsic, Ami A Shah, Thomas A Medsger, Zsuzsanna H McMahan, Arthritis Care & Research
Press Mentions
The 2024 ARP President’s & Merit AwardsNovember 26th, 2024
My First Question Is — What Is Your Antibody Type? I Can Better Comment on the Issue of “Spontaneous Remission” Once I Know ThatJanuary 9th, 2017- Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)September 19th, 2023
Grant Support
- Relaxin In Systemic Sclerosis W/ Diffuse SclerodermaNational Center For Research Resources2000–2002
- Double Blind Study With Oral Iloprost And Placebo In Raynaud'S PhenomenonNational Center For Research Resources1997
- Multicenter Evaluation Of Pilocarpine HCL In Sjogrens SyndromeNational Center For Research Resources1996–1997
Professional Memberships
- Master Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
